Testing a new imaging tool for brain tumor surgery
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This study tests a new imaging device called cCeLL that helps doctors see brain tumor tissue during surgery, making diagnosis faster and more accurate. It is for adults who are already scheduled for brain tumor removal surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a brain tumor that is scheduled for surgery to remove it.
- Your tumor is at least 1 centimeter (about the size of a pea) in size.
- You understand the study and agree to sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device (CCeLL-In Vivo) that may help surgeons tell tumor from normal brain tissue during an operation, which could improve how much tumor is removed while protecting healthy brain.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
This trial tests whether a special dye called ICG, which glows under infrared light, can help surgeons better see and remove bone and soft tissue tumors during surgery. The goal is to make the removal more precise and safe.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
This study tests a new dye called SBK2-ICG that helps surgeons see brain tumors more clearly during surgery. The dye is given before surgery and may help your doctor remove more of the tumor safely.
Hear when a new Indocyanine Green (ICG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.